DistantNews
Support us
AI systems emerge as "Co-Researchers," accelerating scientific discovery
๐Ÿ‡ฌ๐Ÿ‡ท Greece /Health & Science

AI systems emerge as "Co-Researchers," accelerating scientific discovery

From Kathimerini · () Greek

Translated from Greek, summarized and contextualized by DistantNews.

At a glance

News Sources not specified New plan
  • Two new AI systems, Google's Co-Scientist and FutureHouse's Robin, are described as "Co-Researchers" that actively collaborate with humans in scientific discovery.
  • These AI systems can generate hypotheses, design experiments, and analyze data, significantly reducing research time.
  • Co-Scientist successfully identified potential drug candidates for acute myeloid leukemia and Robin is being used to find treatments for age-related macular degeneration.

The scientific community is abuzz following the publication of two groundbreaking AI systems that function as active collaborators in research. Nature, a leading scientific journal, fast-tracked the release of details on Google's Co-Scientist and FutureHouse's Robin, systems designed to work alongside human scientists.

These AI "Co-Researchers" are capable of much more than just assisting; they actively participate in the knowledge creation process. They can sift through scientific literature, formulate hypotheses, design experiments, and interpret results, dramatically accelerating the pace of discovery. Unlike single AI models, both Co-Scientist and Robin utilize "swarms" of specialized AI agents that collaborate like a human research team.

These agents perform distinct roles: some handle literature reviews, others generate hypotheses, some act as "critics" evaluating different ideas, and others analyze data. Through internal "discussions" and challenges, these agents refine scientific hypotheses. For instance, Co-Scientist was tasked with identifying existing drugs that could be repurposed for acute myeloid leukemia. It proposed five candidates, three of which proved effective in lab tests on cancer cell lines. One drug, Binimetinib, showed particularly low toxicity to cancer cells, suggesting a potential therapeutic window.

Co-Scientist also made significant strides in microbiology. When asked to explain how antibiotic resistance genes appear across diverse bacterial species, the AI formulated a hypothesis within two days. This hypothesis, suggesting that specific viral particles interact with bacteriophage tails to broaden host range, mirrored findings from an independent research team published concurrently in Nature after a decade of study.

Meanwhile, the Robin system is being applied to find treatments for age-related macular degeneration, a leading cause of blindness in developed countries. Robin is exploring phagocytosis, the cellular "cleaning" function of retinal cells, as a potential therapeutic avenue.

DistantNews Editorial

Originally published by Kathimerini in Greek. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.